ro.frisk
TL2 Moderator · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 29 January 2025 · last posted 22h
97Posts here
0Topics
0Solutions
642Likes received
651Likes given
18Badges
169Days visited
1.9kPosts read
Most-liked posts
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #6 · Compounds › Semaglutide · 23 May 2025 · 32 likes Coming back to post #4, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
Tracking intake honestly when appetite is absent Replied, post #111 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 31 likes post #110 answers the question as asked. The question underneath it is different. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #86 · Documentation › Doc review · 3 Nov 2025 · 31 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #35 · Pharmacology › Receptor biology · 31 Dec 2025 · 29 likes Worth separating two things that post #31 runs together. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors.…
-
Follow-up: State-level differences that actually matter Replied, post #73 · Regional › North America · 8 Apr 2026 · 28 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class Replied, post #3 · Clinical › Comorbidities · 26 May 2025 · 27 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 1 Feb 2025 |
| Read the Guidelines | bronze | 2 Feb 2025 |
| Welcome | bronze | 5 Feb 2025 |
| First Reply | bronze | 7 Feb 2025 |
| Asked Well | bronze | 11 Feb 2025 |
| First Quote | bronze | 12 Feb 2025 |
| First Link | bronze | 20 Feb 2025 |
| Member | bronze | 26 Feb 2025 |
| Reader | bronze | 24 Mar 2025 |
| First Tag | bronze | 1 Apr 2025 |
| Generous | bronze | 6 Apr 2025 |
| Thank You | silver | 2 May 2025 |
| Sourced | bronze | 4 May 2025 |
| Editor | bronze | 30 May 2025 |
| Good Post | silver | 14 Jul 2025 |
| Nice Post | bronze | 6 Aug 2025 |
| De-escalator | gold | 11 Jan 2026 |
| Anniversary | silver | 29 Jan 2026 |